Literature DB >> 8599421

Possible antidepressant effect of minocycline.

J Levine, A Cholestoy, J Zimmerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8599421     DOI： 10.1176/ajp.153.4.582b

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  16 in total

Review 1.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

Review 2.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

Review 3.  Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?

Authors:  Karen Wager-Smith; Athina Markou
Journal:  Neurosci Biobehav Rev       Date:  2010-09-29       Impact factor: 8.989

Review 4.  Minocycline: therapeutic potential in psychiatry.

Authors:  Olivia M Dean; João Data-Franco; Francesco Giorlando; Michael Berk
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

5.  Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors.

Authors:  Marta Imbesi; Tolga Uz; Radmila Manev; Rajiv P Sharma; Hari Manev
Journal:  Neurosci Lett       Date:  2008-10-07       Impact factor: 3.046

Review 6.  Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

Authors:  Helena M Abelaira; Gislaine Z Réus; Fabricia Petronilho; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

Review 7.  Neuroinflammation and psychiatric illness.

Authors:  Souhel Najjar; Daniel M Pearlman; Kenneth Alper; Amanda Najjar; Orrin Devinsky
Journal:  J Neuroinflammation       Date:  2013-04-01       Impact factor: 8.322

8.  A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI.

Authors:  Kenji Hashimoto; Tamaki Ishima
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

9.  Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial.

Authors:  Jonathan Savitz; Sheldon Preskorn; T Kent Teague; Douglas Drevets; William Yates; Wayne Drevets
Journal:  BMJ Open       Date:  2012-02-22       Impact factor: 2.692

10.  A bipolar disorder patient becoming asymptomatic after adjunctive anti-filiarasis treatment: a case report.

Authors:  Nora Hamdani; Raphaël Doukhan; Aline Picard; Ryad Tamouza; Marion Leboyer
Journal:  BMC Psychiatry       Date:  2013-03-13       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.